Myocarditis;Myokarditidy

Vnitrni Lekarstvi

Volumn 46, Issue 11, 2000, Pages 801-807

  Gregor, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Diagnosis of Myocarditis; Etiology of myocarditis; Myocarditis; Therapy of myocarditis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEART ENZYME; IMMUNOSUPPRESSIVE AGENT;

ANTIBIOTIC THERAPY; BED REST; CARDIOGENIC SHOCK; CLINICAL FEATURE; COXSACKIE VIRUS B; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART CONDUCTION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HUMAN; MYOCARDITIS; PREVALENCE; REVIEW;

ELECTROCARDIOGRAPHY; HUMANS; MYOCARDITIS;

EID: 0033680491     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus
2. Idiopathic giant-cell myocarditis - Natural history and treatment
3. A nonsteroid anti-inflammatory drug exacerbates coxsackie B3 murine myocarditis
4. Verapamil ameliorates the clinical pathological course of murine myocarditis
5. Gama-globulin treatment of acute myocarditis in the pediatric population
6. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients
7. Search of Coxsackie B3 RAN in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction
8. Incidence of myocarditis: A 10-year autopsy study from Malmo, Sweden
9. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomycardial biopsy
10. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice
11. Role of oxygen derived free radicals in pathogenesis of coxsackievirus B3 myocarditis in mice
12. Exercise in coxsackie B3 myocarditis: Effects of heart lymphocyte subpopulations and the inflammatory reaction
13. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine coxsackievirus B3 myocarditis
14. Treatment of chronic myocarditis with corticosteroids
15. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID)
16. Task Force 3: Hypertrophic cardiomyopathy, myocarditis and other myocardial diseases and mitral valve prolapse
17. Acute myocarditis rapid diagnosis by PCR in children
18. A clinical trial or immunosuppressive therapy for myocarditis
19. Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changes
20. Heart transplantation in dilated heart muscle disease and myocarditis
21. Coxsackie B3 murine myocarditis: Deleterious effects of nonsteroidal anti-inflammatory agents
22. Effect of metoprolol in coxsackie virus B3 murine myocarditis
23. Treatment of viral myocarditis with focus on captopril
24. Diagnostic, surveillance and epidemiologic evaluation of viral infections in pediatric cardiac transplantant recipients with the use of the polymerase chain reaction
25. Effects of angiotensin converting enzyme inhibitors on myocardial injury and congestive heart failure due to myocarditis in mice: Comparison with captopril and enalapril
26. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis
27. An angiotensin II receptor antagonists reduces myocardial damage in an animal model of myocarditis
28. Myocarditis
29. Detgection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues
30. Variations in the susceptibility for congenital inbred mice to Coxsackie B3 induced myocarditis among different strains of mice
31. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus